Literature DB >> 14521591

The function of factor XI in tissue factor-initiated thrombin generation.

S Butenas1, J D Dee, K G Mann.   

Abstract

The influence of plasma and platelet factor (F)XI on thrombin generation initiated with 10 pm tissue factor (TF) in a synthetic coagulation model was evaluated in the presence of either 2 x 108 mL-1 platelets or the equivalent (2 microm) phospholipids. In either system, with all proteins present at physiological concentrations, FXI (30 nm) had no effect on thrombin generation. With phospholipids in the absence of FXI, an increase in vitamin K-dependent proteins (VKDP) (up to 500%) significantly prolonged the initiation phase of thrombin generation and decreased maximum thrombin levels. The inhibition was principally caused by the elevated prothrombin and FIX concentrations. When 30 nm FXI was added with elevated VKDP and phospholipids, the initiation phase was decreased and the maximum thrombin levels generated substantially increased. In experiments with platelets (with and without plasma FXI), an increase in VKDP had little effect on the initiation phase of thrombin generation. These data indicate that (i) FXI has no effect on thrombin generation at 10 pm TF and physiological concentrations of VKDP; (ii) platelets and plasma FXI are able to compensate for the inhibitory effects of elevated VKDP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521591     DOI: 10.1046/j.1538-7836.2003.00431.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  9 in total

1.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

2.  Membrane binding events in the initiation and propagation phases of tissue factor-initiated zymogen activation under flow.

Authors:  Laura M Haynes; Yves C Dubief; Kenneth G Mann
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

3.  Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.

Authors:  Jeffrey W Shupp; Shannon M Prior; Daniel Y Jo; Lauren T Moffatt; Kenneth G Mann; Saulius Butenas
Journal:  Burns       Date:  2017-10-09       Impact factor: 2.744

4.  Correlation between factor (F)XIa, FIXa and tissue factor and trauma severity.

Authors:  Shannon M Prior; Mitchell J Cohen; Amanda S Conroy; Mary F Nelson; Lucy Z Kornblith; Benjamin M Howard; Saulius Butenas
Journal:  J Trauma Acute Care Surg       Date:  2017-06       Impact factor: 3.313

5.  Continuous thrombin generation in whole blood: New applications for assessing activators and inhibitors of coagulation.

Authors:  Shannon M Prior; Kenneth G Mann; Kalev Freeman; Saulius Butenas
Journal:  Anal Biochem       Date:  2018-05-07       Impact factor: 3.365

6.  Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.

Authors:  Sarah Goldman; Shannon M Prior; Jan P Bembenek; Maciej Niewada; Elżbieta Broniatowska; Anna Członkowska; Saulius Butenas; Anetta Undas
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

7.  Endogenous Procoagulant Activity in Trauma Patients and Its Relationship to Trauma Severity.

Authors:  Shannon M Prior; Myung S Park; Kenneth G Mann; Saulius Butenas
Journal:  TH Open       Date:  2019-01-07

8.  Peri- and Postpartum Management of Patients With Factor XI Deficiency.

Authors:  Gloria F Gerber; Kelsey A Klute; John Chapin; James Bussel; Maria T DeSancho
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

9.  Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke.

Authors:  Piotr Kusak; Danuta Czarnecka; Matthew Gissel; Krzysztof Plens; Saulius Butenas; Anetta Undas
Journal:  Arch Med Sci       Date:  2015-11-17       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.